
Dentists may one day be able to replace missing teeth with ones newly grown from gum cells, say UK researchers.

Dentists may one day be able to replace missing teeth with ones newly grown from gum cells, say UK researchers.

With a new pair of stylish shades, people with colorblindness are beginning to see the world just as the rest of us do. The corrective glasses were actually created as tools to detect blood oxygenation and flow beneath the surface of the skin. But then colorblind people started trying them on, and they began to see the world in a whole new way.

Organovo is the developer of the NovoGen MMX Bioprinter™, the world’s only commercial bioprinter proven to create tissue.
Physicians at Weill Cornell Medical College and biomedical engineers at Cornell University have succeeded in building a facsimile of a living human ear that looks and acts like a natural ear. Researchers believe their bioengineering method will finally succeed in the long quest by scientists and physicians to provide normal looking “new” ears to thousands of children born with a congenital ear deformity.

3D printing technology has helped replace 75 percent of a patient’s skull with the approval of U.S. regulators.

The flexible needles could help doctors deliver stem cells to broader areas of the brain with fewer injections. Such therapies are being investigated for Parkinson’s diseases, stroke and other neurodegenerative diseases

Scientists say they have published the most detailed brain scans “the world has ever seen” as part of a project to understand how the organ works.

Researchers today described the first documented case of a child being cured of HIV. The landmark findings were announced at the 2013 Conference on Retroviruses and Opportunistic Infections in Atlanta, GA.

Vein Illumination is revolutionizing venipuncture with AccuVein’s award winning solution. In venipuncture, you have very little margin for error. Imagine how much more effective you’d be if you could visualize veins that are beneath the skin.

Fresh insights into the protective seal that surrounds the DNA of our cells could help develop treatments for inherited muscle, brain, bone and skin disorders.

The body’s immune system exists to identify and destroy foreign objects, whether they are bacteria, viruses, flecks of dirt or splinters. Unfortunately, nanoparticles designed to deliver drugs, and implanted devices like pacemakers or artificial joints, are just as foreign and subject to the same response.

Predicting the future of health care is a tricky business. At any point, there could be a big breakthrough in, say, cancer research, throwing the whole thing off. Or a new technology could come along in another sector, disrupting health care just as a side effect (much like the smartphone has already done). FutureMed, a weeklong program from Singularity University for doctors and others in the health care industry, looks at the ways that technology could change health care in the coming years. I spent a day at Singularity’s classroom (located at the NASA Research Park in Silicon Valley) to soak up some of the predictions. Here are some of the biggest takeaways.

Taking blood is a fine art. Even the most experienced practioner may require more than one stab to find a vein—seems only natural to wonder, might a robot do the job better? Mountain View’s Veebot thinks so. Veebot wants to take the art out of needlework with their robotic venipuncture machine.

The Food and Drug Administration on Thursday approved the nation’s first “artificial retina,” a highly anticipated advance that could give limited vision to adults rendered blind by a rare genetic disorder.
In May 2009, DARPA initiated the Blue Angel effort to identify ongoing programs to assist in the Government-wide response to the H1N1 pandemic. The Blue Angel program is an accelerated and integrated effort to deliver effective interventions for pandemic influenza. Blue Angel brings together the following technologies to form a comprehensive approach in response to a pandemic influenza or manmade outbreak: Predicting Health and Disease (PHD), a program to predict and diagnose individuals exposed to influenza before they are symptomatic; Modular IMmune In vitro Constructs (MIMIC®), a program to identify safe and effective treatments in a test tube; and Accelerated Manufacture of Pharmaceuticals (AMP), a capability for rapidly mass producing low-cost, vaccine-grade recombinant protein that has the potential for scale up to tens of millions of doses per month. In response to the 2009 H1N1 swine flu pandemic, Blue Angel programs are currently in a “live-fire test” to demonstrate a flexible and agile capability for the Defense Department to rapidly react and neutralize any natural or intentional pandemic disease.